EpiBiologics, Inc. — Form D
EpiBiologics, Inc. of SAN MATEO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-28. The offering totals $50.0M, of which $30.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-28
- Form: D
- Accession: 0001968158-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $30.0M
- Remaining: $20.0M
- Investors: 13
- Date of first sale: 2022-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-480390
Issuer
- Name: EpiBiologics, Inc.
- CIK: 0001968158
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1900 ALAMEDA DE LAS PULGAS, SAN MATEO, CA, 94403
- Phone: (650) 452-3510
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Rami Hannoush | Director | San Mateo, CA |
| Michael Kavanaugh | Director | San Mateo, CA |
| Rami Hannoush | Executive Officer | San Mateo, CA |
| Craig Lichtenstein | Executive Officer | San Mateo, CA |
| Alexandra Cantley | Director | Newton, MA |
| Jason Coloma | Director | AUSTIN, TX |
| Ann Lee-Karlon | Director | San Mateo, CA |
| Ann Lee-Karlon | Executive Officer | San Mateo, CA |
| Samuel Bjork | Director | Cambridge, MA |
| Mitchell Mutz | Director | Seattle, WA |
| Mitchell Mutz | Executive Officer | Seattle, WA |
| Seiji Miyahara | Director | San Mateo, CA |
| James Wells | Director | Vancouver, A1 |
Other filings by this issuer (1)
More